Detalles de la búsqueda
1.
Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations.
BJU Int
; 2024 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403809
2.
Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancer.
Prostate
; 83(10): 950-961, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37074030
3.
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 383(13): 1218-1230, 2020 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32945632
4.
High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation.
Acta Oncol
; 61(10): 1179-1185, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36062835
5.
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
Future Oncol
; 18(19): 2361-2371, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416053
6.
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223.
Eur J Nucl Med Mol Imaging
; 48(10): 3325-3334, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33686456
7.
High rate of local control and cure at 10 years after treatment of prostate cancer with external beam radiotherapy and high-dose-rate brachytherapy: a single centre experience.
Acta Oncol
; 60(10): 1301-1307, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34498986
8.
No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.
World J Urol
; 38(2): 381-388, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31020424
9.
Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial.
Oncologist
; 24(6): 745-e213, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30552156
10.
Caspase-3-dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells.
Blood
; 128(23): 2655-2665, 2016 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27742710
11.
The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?
Acta Oncol
; 61(12): 1515-1516, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484326
12.
Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts.
Acta Oncol
; 56(1): 21-26, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27882806
13.
First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies.
Invest New Drugs
; 33(6): 1232-41, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553306
14.
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma.
BMC Cancer
; 14: 408, 2014 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24906441
15.
Outside the box of immunotherapy - new hope for patients with advanced urothelial cancer.
Acta Oncol
; 58(7): 951-952, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31232133
16.
Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience.
Radiat Oncol
; 19(1): 74, 2024 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38880908
17.
Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021: a population-based survey.
Scand J Urol
; 59: 19-25, 2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38226846
18.
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance.
Eur Urol
; 85(2): 154-163, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37714742
19.
Clinical activity of sorafenib in a previously treated advanced urothelial cancer patient.
Anticancer Drugs
; 24(6): 648-52, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23542751
20.
Optimal Systemic Treatment of Advanced Bladder Cancer Calls for a Multidisciplinary Approach.
Cancers (Basel)
; 15(3)2023 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765518